HAVCR2 and B-cell chronic lymphocytic leukemia: Overexpression of TIM-3 on exhausted CD4+ and CD8+ T cells and leukemic cells in patients with chronic lymphocytic leukemia (CML), acute lymphoblastic leukemia (ALL), and CLL, might be a prognostic factor for poor therapeutic response and relapse in patients.